HHS Privacy: Paid Third-Party Communications Excluded From “Marketing”
Executive Summary
Written drug treatment communications from a paid third party will no longer fall under the definition of "marketing" under HHS' proposed changes to its privacy rule
You may also be interested in...
Rx Marketing: Florida Subpoenas Manufacturer Agreements With Pharmacies
The Florida Attorney General has subpoenaed a number of pharmaceutical manufacturers for documents related to marketing agreements with pharmacies
Rx Marketing: Florida Subpoenas Manufacturer Agreements With Pharmacies
The Florida Attorney General has subpoenaed a number of pharmaceutical manufacturers for documents related to marketing agreements with pharmacies
“Marketing” definition in privacy rule
Further revisions to definition of "marketing" under HHS' proposed privacy rule modifications are likely, Healthcare Leadership Council President Mary Greely tells a press briefing April 4. "There might be some expansion or better definition in this area because I think it is one that people are going to comment on," Greely said. Under HHS' March 27 proposed modifications, written communications from a paid third party will not be considered "marketing" if they are related to drug treatment (1"The Pink Sheet" March 25, p. 13)...